current studies on the pathogenesis of morbilli form and bullous exanthems, which include the most severe drug-induced cutaneous hypersensitivity reactions.
Although immediate-type hypersensitivity reaC tions, such as urticarial exanthems and anaphylaxis, are mediated by drug-specific 19B antibodies, the pathogenesis of delayed-type hypersensitivity reactions, such as morbilliform or bullous eruptions, has not been fully elucidated [2] .
Sulfonamides, f3-lactam antibiotics, anti-epileptic agents (particu larly phenytoin), and nonsteroidal anti-inflamm atory drugs are the major causes of drug-induced toxic epidermal necrolysis (TEN) and Stevens-Johnson syndrome (reviewed in [3] ). There is in vivo and in vitro evidence that T lymphocytes are involved in the pathogenesis of drug-induced cutaneous reactions, in that peripheral blood mononuclear cells (PBMC) from patients with drug-induced im mediate-type reactions (urticaria) and delayed hypersensitivity re actions (morbill iform and bullous exanthems) frequendy can be stimulated in vitro with the causative drug [4, 5] . In additi on, several histologic studies have demonstrated that the inflamm atory infil trate in drug-induced delayed cutaneous hypersensitivity reactions is primarily composed oflymphocytes. This brief review focuses on Abbreviations: LTT, lymphocyte transformation test; SMX, sulfame thoxazole; TEN, toxic epidennal necrolysis.
thems were predominantly T-cell receptor a//l+, CD4+, COS-and displayed a Th2-like cytokine pat tern. CDS+ dermal T cells from a sulfamethoxazole induced bull ous exanthem proliferated in vitro in response to sulfamethoxazole. This T-cell prolifera tion was significantly increased in the presence of microsomes, which suggests that microsomal en zymes, such as cytochrome P450 enzymes, generate highly reactive metabolites which are the nominal antigens for T-cell activation. In summ ary. drugs may be processed and presented in di1Ferent ways, which ill reflected by the observation that Thl-like CDS+ T cells are primarily activated in delayed cutaneous hypersensitivity reactions, whereas Th2-like T-cell responses are present in patients with drug-induced urticarial exanthems. Kq ",om: cnB+ T cells/drug hypevsensitivity/lrmphOC}'te transjormation/,,", JOY histocompatibility complexlcrtochyome P450lhaptens.
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current studies on the pathogenesis of morbilli form and bullous exanthems, which include the most severe drug-induced cutaneous hypersensitivity reactions.
IN VIVO STUDIES
hnmunohistochemical Findings Immunohistologic studies in drug-induced TEN, Stevens-Johnson syndrome, and erythema multiforme have shown that the dermal infiltrate is composed mainly of CD4+ T lymphocytes, whereas mononuclear cells disposed along the epidermal junction and migrating into the epidermis are CD8+ T lymphocytes [6] [7] [8] [9] . Studies by Osawa et al [10] demons !;rated a predominance of epidermal CD8+ T cells in drug-induced bullous exanthems, whereas lichen planus-like and morbill iform exanthems were characterized by both CD4+ and CD8+ epidermal and dermal T cells. No definitive data are available regarding the frequency of drug-specific T cells in the epidermal and dermal infiltrate. The clinical and histologic picture ofTEN shows striking similarity to that of severe graft versus host reaction [9] . Cell-mediated cytotoxicity of lymphocytes against epidermal cells may explain the pathologic finding of "satellite cell necrosis" (necrotic keratinocytes adjacent to mononuclear cells) in the early phase of drug-induced TEN as in acute cutaneous graft vmus host reaction [9] . Most immunohistochemical studies ofTEN have also found variable degrees of up-regulation of intercellular adhesion molecule-l (IeAM-l) and human leukocyte antigen (HLA)-DR on keratinocytes in involved skin, which is presumably due to cytokine secretion by infiltrating T cells [7, 8, 11] . Several 
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96S HERTL AND MERK studies have also characterized the inflammatory infiltrate of fixed drug eruptions [12] . As in the above-mentioned bullous exanthems, CDS+ T cells were the predominant epidermal subset and were still detectable at the epidermal junction 3 weeks after the resolu tion of fixed drug eruptions [13] . This persistence of potentially drug-specific T cells in the skin may explain why fixed drug eruption reappears at the same site upon rechallenge with the particUl ar drug. A focal dysregulation of the interferon-,}, (IFN-'}') induced up-regulation of ICAM-l on epidermal keratinocytes has also been implicated as a pathogenic factor in fixed drug eruptions [14] .
IN VITRO STUDIES

Lymphocyte Transformation Test (LTT).
The LIT has a long history as an in vitro assay for detection of drug-specific lymphocyte activation [4, 5, 15, 16] . PBMC from patients with cu taneous hypersensitivity reactions are co-cUl tured with the caus ative agents, and lymphocyte activation is determined after 5-7 d by the incorporation of radioactive thymidine [5, 15] . This test has been reported to give positive resUl ts with a variety of drugs, including f3-lactam antibiotics, antiepileptic agents, sulfonarnides, nonsteroidal anti-inflamm atory drugs and others [4, 5, 15, 16] . Per forming phenotypic analysis, Koponen et at [17] found that CD4+ T cells were the major T-cell subset activated upon co-cUlture with penicillin s in vitro. The LTT provided some evidence that penicil loyl, the major metabolite of benzylpenicillin, plays a role as a nominal antigen in that PMBC of some penicillin -allergic patients were activated in vitro by both benzylpenicillin and penicilloyl [15] . PBMC from penicillin-allergic individuals were occasionall y acti vated by the first-generation cephalosporin cephalothin, which is presumably hydrolyzed to a cephaloyl derivative that is structurally related to penicilloyl [15] . A major problem associated with inter pretation of LIT resUlts is the lack of appropriate controls, i.e., PBMC from healthy controls treated with the investigated drug but without allergic reaction. Drug-induced lymphocyte proliferation is frequently low, which makes it hard to distinguish between positive and false-negative results. This is important because PBMC from healthy donors can occasionally be stimulated in vitro by the tested drug [5, 15] . In our experience, the PBMC from six of 25 healthy volunteers were stimUl ated in vitro by benzylpenicill in; all of the responders had been treated with f3-lactam antibiotics in the past [15] . Stejskal et at [lS] also found benzylpenicillin -specific lympho cyte proliferation in the LIT and benzylpencillin -specific IgG antibodies in healthy individuals with occupational exposure to penicillin s. Another disadvantage of the LIT is the limited knowl edge of the frequency of drug-specific precursor T cells in the peripheral blood. The lack of reproducibility of T-cell stimulation by the causative drug in the LTT may resUlt from low frequency of the drug-specific precursor cells. This is reflected by the observa tion of Roujeau et at [16] that the drug-induced proliferation of PBMC from TEN patients, seen in vitro at the onset of clinical symptoms, was virtuall y absent months later.
Generation of Drug-Speciftc Peripheral and Lesional T Cell Clones From Patients With Morbilliform and Bullous
Drug Eruptions In a recent study, exclusively CDS+ epidermal T-cell clones were isolated from f3-lactam-induced bullous exan thems and patch-test reactions [11] . Three epidermal CDS+ T-cell clones proliferated to the particUl ar f3-lactam antibiotic in a major histocompatibility complex (MHC)-restricted fashion and pro duced TH1-pattern cytokines after activation [11] . Identical obser vations were made with peripheral f3-lactam-specific T-cell clones from patients with morbilliform exanthems, which were exclu sively CDS + and proliferated in response to benzylpenicillin and to its major metabolite penici11 0yl [19] . These clones also secreted Thl-like cytokines. The predominant generation of epidermal CDS+ T lymphocytes is unlikely to be a cUl ture artifact in that CD4+ antigen-specific T-cell clones were predominantly gener-THE JOURNAL OF INVESTIGATIVE DERMATOLOGY ated from positive epicutaneous test reactions to fragrances* and CD4 + T-cell lines specific for tetanus toxoid from the peripheral blood of immunized donors [19] . In addition, more CP4+ than CDS+ peripheral T-cell lines were derived from patients (n = 3) with penicillin -induced urticarial exanthems (unpublished observa tion). The CD4+ T-cell lines displayed a TH2-like cytokine pattern in that they produced interleukin-4 (JL-4), no IFN-,}" and low amounts ofIL-2. These CD4+ T cells may provide help for B cells to produce penicillin -specific 19B antibodies, which have a critical function in drug-induced immediate hypersensitivity reactions.
Current concepts attribute two diff erent functions to CDS+ T cells; an IFN-y-producing subset plays a role in cell-mediated cytotoxicity, and an IL-4-producing popUl ation provides help for IgE production by B cells and suppresses the activation of CD4+ helper Thl-like cells [20] . Because the epidermal-derived CDS+ T-cell clones were cytotoxic in vitro against epidermal keratinocytes and B cell lines [11] , we specUl ate that they act as cytotoxic effector cells in vivo. Several studies have shown that CDS+ T-cell lines with cytotoxic activity can mediate delayed-type infl amm atory reactions it, vivo [21] . It is unclear why drug-specific CDS+ T lymphocytes preferentially localize in the epidermis. This phenom enon is not unique to drug reactions; epidermal CDS+ T cells were also expanded from lesional skin of patients with psoriasis vUl garis [22] or graft versus host disease [23] . CDS+ T lymphocytes have also been identified as effector cells in allergic contact dermatitis [24] and in humans all ergic to the hapten poison ivy [25] . All f3-lactam-specific epidermal CDS+ T-cell clones produced signif icant amounts ofIFN-,}" which is known to induce up-regulation of ICAM-l on endothelial cells and keratinocytes [26, 27] . Up-regu lation ofICAM-l on keratinocytes in cutaneous drug reactions may be due to the release of IFN-'}' by infiltrating T cells [27,2S] . ICAM-l, the ligand for leukocyte function-associated antigen-l on T cells, is a critical adhesion molecUl e for the homing of T lymphocytes into the skin [26] . Interaction of leUkocyte function associated antigen-l and ICAM-l also plays a critical role in T-cell-mediated cytotoxicity [29] . Epidermal T cells isolated from various drug-induced bullous exanthems (f3-lactam antibiotics, n = 5; carbamazepine, n = 2; sulfamethoxazole, n = 2; acetylsalicylic acid, n = 1) were uniformly T-cell receptor a/f3+, which is in keeping with the findings of Foster et at [30] .
Role of Drug Metabolism in the Formation of the Nominal
Antigens Most drugs are m�tabolized by cytochrome-P450-dependent enzymes to highly reactive derivatives, which may be detoxified or act as a toxic agent (or immunogenic hapten) [2, 4] . The activities of these P450-dependent isoenzymes exhibit genetic polymorphism, and the genes of more than 300 isoenzymes have already been cloned; this may explain the heterogeneity of the individual response to the particUlar drug. .
Phenytoin is metabolized by cytochrome-P450-dependent en zymes into a highly reactive arene-oxide metabolite, which is detoxified primarily by epoxide hydrolases [31, 32] . This compound is highly toxic to cells but may also bind to proteins. The increased toxicity of phenytoin to lymphocytes of phenytoin-allergic patients indicates that a polymorphism in the activity of the epoxide hydrolase may be the cause for this syndrome [31] . Shear and Spielberg [31] prop.osed the use of the lymphocyte toxicity assay for in vitro diaguosis of the phenytoin hypersensitivity syndrome because PBMC from. patients with this syndrome are highly susceptible to the toxic effects of cytochrome-P450-dependent metabolites of most (not chemically related) anti-epileptic drugs, including phenytoin, carbamazepine, and phenobarbital (though not valproinic acid).
Sulfamethoxazole (SMX) is metabolized by acetylation to N4-cetyl-SMX and by cytochrome P450 to 5-hydroxy-SMX or to a reactive hydroxylamine [33, 34] . The hydoxylamine derivative may be detoxified by glutathione synthetase or may bind to macromol- [33] . Cytochrome-P450-dependent SMX metabolites may be important in the pathogenesis of SMX induced hypersensitivity reactions because an SMX-specific CD8+ dermal T-cell clone from an SMX-induced bullous exanthem showed a significantly increased proliferation to SMX in the presence of microsomes rich in cytochrome P450 [34] . This observation suggests that cytochrome,.P450-dependent SMX me tabolites were relevant T-cell antigens. This finding is of particular interes� because recent studies have indicate.d that some patients with sulfunamide-induced bullous C\ltaneous eruptions exhibit reduced N-acetylating capacity.:j: In addition, patients with in creased cytochrome-P450-dependent metabolism of sulfonamides to hydroxylamine derivatives have an increased risk to develop drug-induced hypersensitivity reactions [3 5 ]. Analogous to the findings in the phenytoin hypersensitivity syndrome, the toxicity of the hydroxylamine metabolite of SMX was greatest for PBMC from SMX-allergic patients [2, 34]. Kalish et al [36 ] have also demonstrated that T lymphocytes reactive to SMX are present at low frequencies in the peripheral blood of patients with drug eruptions secondary to treatment with s,*,onamides. Maurl-Hell weg et al observed an increased expression of CD25 (lL-2R) and lILA-DR (MHC IT) on peripheral CD4+ and CD8+ T cells from allergic donors stimulated in vitro with SMX. § Supernatants from these cultures contained high amounts ofIL-5, which was presum ably produced by SMX-activated T cells. In vitro cultures with SMx in�ced the preferential expansion of CD25+ T-cell receptor V/U 7 + T cells, suggesting that: �g-activated T cells displayed a limited T-cell receptor usage.
Niederau et al [37] have also provided evidence for the role of cytochrome-P450-dependent enzymes in the generation of the nominal antigens recognized by lymphocytes from pyrazolone sensitized individuals. PBMC from eight patients with hypersensi tivity reactions to the pyrazolone derivatives metamizole, propy phenazone, and phenazone were strongly stimulated by these 4rugs in the presence of cytochrome-P450-enriched microsomes, whereas co-culture with the parent drugs alone caused absent or significantly less lymphocyte proliferation.
Penicillins hydrolyze spontaneously to form a penicilloyl group (which can covalendy bind to either amino or sulfhydryl groups of proteins) and to the so -call ed minor determinants [38] [39] [40] . The relevance of the binding of penicilloyl to albumin has been confirmed in vivo in that patients receiving benzylpenicillin showed a dose-dependent saturation of serum albumin with penicilloyl [40] . As mentioned earlier, penicilloyl can stimulate penicillin -specific T cells [15, 34] . The penicillin -specific IgE antibody response is heterogeneous in that antibodies against the common J:J-lactam ring structure and various side-chain determinants are present in the sera of penicillin -allergic patients [39] . In many instances, only antibod ies against the side-chain determinants of 13-lactam antibiotics are found [9, 18] . Side-chain-specific lymphocyte proliferation has been demonstrated in individuals with occupational exposure to the ampicillin derivative a-aminobenzylpenidllin ester (bacampicillin ). In these patients, FUMC proliferated in response to the N-acyl amido side chain and the ester group of the bacampicillin molecule, but not to benzylpenicilli it , penicillin V, or 6-aminopenicillanic acid [18] . In addition, PBMC from ampicill in-allergic patients were activated in vitro by ampicillin but not by benzylpenicillin [41, 42] .
Penicill oyl-specific IgG antibodies can be found in the sera of healthy individuals treated with petrlci11ins [40] . However, the presence of benzylpenicillin -specific 19B antibodies is generally linked to the occurrence of penicillin -induced allergic reactions [40] . Haptens , such as drugs and small -molecular-weight contact sensi tizers, interact with proteins by a variety of cheniical reactions and have a broad range of physical properties [4, 43] . This diversity in hapten chemistry is probably reflected in diversity of antigen processing and presentation. Functional data suggest that drugs preferentially activate (:D8+ T cells but also activate CD4+ T cells [11, 19, 34] . The predominant activation QfCD8+ T cells suggests that the processing of drug-conjugated proteins proceeds by the endogenous pathway. Because most drugs are exogenoqs sub stances, they may be internalized, conjugated to intracellular proteins, and presented by MHC I molecules to CD8+ T cells. The penicilloyl moiety, the major penicillin metabolite [38, 39] . seems to playa role in penicillin -specific T-cell �tivation, as benzylpenicil lin-specific CD8+ T-cell clones were also significantly stimulated by penicilloyl [ 34] . Pichler [5] reported that PBMC from penicillin allergic patients can be optimally stimulated in vitro with unmodi fied benzylpenicillin . In some instances, less vigorous in vitro lymphocyte stimulation could also be achieved with benzylpenicil lin coupled to albumin [5] . Bell and Pichler [44] found that glutaraldehyde-fixed antigen-presenting cells acted as sufficient antigen-presenting cells for penicillin -induced T-cell proliferation, suggest:ip.g that penicill in can bind directly to MHC molecules or MHC-associated endogenous peptides. Direct interaction with MHC II molecules has been demonstrated for the hapten gold [45] . In our experience, paraformaldehyde fixation significantly dimin ished the ability of Epstein-Barr virut-tran sformed B-cell lines to present benzylpenicillin to benzylpenicillin -specific CD8+ T-cell clones, suggesting that processing was required [11] . Regarding the nature of the complete antigen, Claas et al [46] demonstrated that benzylpenicillin-treated lymphocytes are no longer susceptible to the cytotoxicity of HLA typing sera against certain MHC I haplo types. This observation suggests that penicillins bind to MHC I antigens. Sparse evidence for the preferential association of drugs with certain MHC haplotypes is given from linkage studies based on the MHC haplotypes of patients with drug-induced cutaneous hypersensitivity reactions [47]: sulfonamide-induced TEN is asso ciated with lILA-A29, HLA-BI2, and HLA-DR7; and so is sulfon amide-induced Stevens-Johnson syndrome (HLA-A29, m.A-B44, HLA-DR7). Herpes simplex-associated erythema multiforme is linked to HLA-BI2 and m.A..,DQ3.
SUMMARY AND CONCLUSIONS Drug-specific CD8+ T lymphocytes are present in the peripheral blood and involved skin of patients with drug-induced delayed cutaneous hypersensitivity reactions, such as morbillifo rm and bullous exanthems. The observed predominance of cytotoxic epi dermlll CD8+ T lymphocytes in drug-induced bullous exanthems suggests that this particular T-cell subset plays a role in the pathogenesis of drug-induced blister formation. In contrast , there is evidence that CD4+ T cells with a TH2-like cytokine pattern are preferentially activated in IgE-mediated cutaneous drug reactions.
The metabolism of the many drugs, for example by cytochrome P450-dependent enzymes, is critical in the f ormation of the nominal T-cell antigens, as demonstrated in the case of SMX dependent T-cell activation. Because of the c�emical properties of haptenic drugs, there seems to be a diversity of processing and presentation pathways of drugs, which is reflected in the activation of both CD8+ THl-like cells in bull ous exanthems and CD4+ TH2-like T lymphocytes in 19B-mediated immediate hypersensi tivity reactions.
